Back
NLS Pharmaceutics Stock Price Chart
Sponsored
NLSP
Sponsored
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
24
NLSP
NLS Pharmaceutics
Last Price:
3.32
Seasonality Move:
34.69%
7 Day Trial
ALL ACCESS PASS
$
7
Start Investing Smarter Unlock Louis Navellier's Stock Grader for free
Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NLSP is experiencing slight selling pressure.
NLS Pharmaceutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.45 | Sell |
20-day SMA: | 3.8 | Sell |
50-day SMA: | 4.59 | Sell |
200-day SMA: | 7.43 | Sell |
8-day EMA: | 3.43 | Sell |
20-day EMA: | 3.81 | Sell |
50-day EMA: | 4.56 | Sell |
200-day EMA: | 9.37 | Sell |
NLS Pharmaceutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.41 | Sell |
Relative Strength Index (14 RSI): | 35.49 | Sell |
Chaikin Money Flow: | -12070 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.45 - 4.61) | Sell |
Bollinger Bands (100): | (4.31 - 7.63) | Sell |
NLS Pharmaceutics Technical Analysis
Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for NLS Pharmaceutics Stock
Is NLS Pharmaceutics Stock a Buy?
- NLS Pharmaceutics share price is 3.29 while NLSP 8-day simple moving average is 3.45, which is a Sell signal.
- The stock price of NLSP is 3.29 while NLS Pharmaceutics 20-day SMA is 3.80, which makes it a Sell.
- NLS Pharmaceutics 50-day simple moving average is 4.59 while NLSP share price is 3.29, making it a Sell technically.
- NLSP stock price is 3.29 and NLS Pharmaceutics 200-day simple moving average is 7.43, creating a Sell signal.
NLSP Technical Analysis vs Fundamental Analysis
Sell
24
NLS Pharmaceutics (NLSP)
is a Sell
Is NLS Pharmaceutics a Buy or a Sell?
-
NLS Pharmaceutics stock is rated a Sell
The current NLS Pharmaceutics [NLSP] share price is $3.29. The Score for NLSP is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
NLS Pharmaceutics Stock Info
Market Cap:
12.55M
Price in USD:
3.29
Share Volume:
66.39K
NLS Pharmaceutics 52-Week Range
52-Week High:
29.08
52-Week Low:
3.00
Sell
24
NLS Pharmaceutics (NLSP)
is a Sell
NLS Pharmaceutics Share Price Forecast
-
What is the NLS Pharmaceutics stock price today?
The NLS Pharmaceutics stock price is 3.29 USD today. -
Will NLSP stock go up or go down?
NLS Pharmaceutics> share price is forecast to RISE/FALL based on technical indicators -
Is NLS Pharmaceutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, NLS Pharmaceutics is overvalued.
Is NLS Pharmaceutics Stock a Buy?
- NLS Pharmaceutics share price is 3.29 while NLSP 8-day exponential moving average is 3.43, which is a Sell signal.
- The stock price of NLSP is 3.29 while NLS Pharmaceutics 20-day EMA is 3.81, which makes it a Sell.
- NLS Pharmaceutics 50-day exponential moving average is 4.56 while NLSP share price is 3.29, making it a Sell technically.
- NLSP stock price is 3.29 and NLS Pharmaceutics 200-day simple moving average is 9.37, creating a Sell signal.
Technical Analysis of NLS Pharmaceutics
Should I short NLS Pharmaceutics stock?
- NLSP Moving Average Covergence Divergence (MACD) indicator is -0.41, suggesting NLS Pharmaceutics is a Sell
- NLS Pharmaceutics Relative Strength Index (RSI) is 35.49, which suggest NLS Pharmaceutics is oversold
- The Bollinger Bands (25) for NLS Pharmaceutics is (3.45 - 4.61), which suggest NLS Pharmaceutics is a Sell
- The Bollinger Bands (100) for NLS Pharmaceutics is (4.31 - 7.63), which suggest NLS Pharmaceutics is a Sell
* NLS Pharmaceutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.